Rao Morubagal Raghavendra, Urs Tejashree Anantharaj, Chitharagi Vidyavathi B, Shivappa Sowmya, Mahale Rashmi Padmanabha, Gowda Ranjitha Shankare, Shree Kavya
Department of Microbiology, JSS Medical College, JSSAHER, Mysore, India.
Iran J Microbiol. 2022 Apr;14(2):174-180. doi: 10.18502/ijm.v14i2.9184.
has emerged as a major organism accounting for hospital acquired infections particularly in intensive care units. Due to production of different kinds of beta lactamases these bacteria have developed drug resistance rendering the treatment of such infections very difficult and expensive. Rapid identification of producing such beta-lactamases is the need of the hour in reducing morbidity and mortality associated with infections.
was isolated from clinical samples like endotracheal aspirates, sputum, urine, exudates using standard culture techniques. Identification and drug sensitivity was done using Vitek 2 system. All the isolates were subjected to detection of ESBLs using phenotypic confirmatory test, plasmid mediated AmpC beta-lactamase by AmpC disc test, Carbapenemase production by CarbAcineto NP Test and Modified hodge method.
149 isolates were analysed for antimicrobial susceptibility and various beta-lactamase production. Results were evaluated for statistical significance using Chi-Square and P value. 81.8% of isolates were from male patients with majority of them above 50 years of age. 88.5% of samples were from ventilator associated pneumonia patients. 83.8% of isolates were sensitive to tigecycline. Only 10% to 12% of isolates were sensitive to carbapenems. 23.4% of isolates were ESBL producers and 46.9% of them were AmpC producers. Modified Hodge test method identified 63.7% of as carbapenemase producers where as CarbAcineto NP test identified 63% and exibiting 94.74% sensitivity, 93.22% specificity when compared to Modified Hodge test.
Multidrug resistant spp. is on the rise. Present study showed that high percentage of drug resistance in could be due to production of ESBLs, AmpC and carbapenemases. Among all beta lactamases carbapenemase producers are more and quickly raising in Rapid, cost effective assay which can be adopted in all clinical laboratories is critical to prevent their further transmission particularly in hospital environment.
已成为医院获得性感染的主要病原菌,尤其是在重症监护病房。由于能产生多种β-内酰胺酶,这些细菌产生了耐药性,使得此类感染的治疗非常困难且昂贵。快速鉴定产生此类β-内酰胺酶的细菌是当下降低与该菌感染相关的发病率和死亡率的迫切需求。
使用标准培养技术从气管内吸出物、痰液、尿液、渗出液等临床样本中分离该菌。使用Vitek 2系统进行鉴定和药敏试验。所有分离株均通过表型确证试验检测超广谱β-内酰胺酶(ESBLs),通过AmpC纸片扩散试验检测质粒介导的AmpCβ-内酰胺酶,通过CarbAcineto NP试验和改良Hodge试验检测碳青霉烯酶的产生。
对149株该菌分离株进行了抗菌药物敏感性和各种β-内酰胺酶产生情况的分析。使用卡方检验和P值对结果进行统计学意义评估。81.8%的分离株来自男性患者,其中大多数年龄在50岁以上。88.5%的样本来自呼吸机相关性肺炎患者。83.8%的分离株对替加环素敏感。只有10%至12%的分离株对碳青霉烯类药物敏感。23.4%的分离株产ESBLs,其中46.9%产AmpC。改良Hodge试验方法鉴定出63.7%的该菌为碳青霉烯酶产生菌,而CarbAcineto NP试验鉴定出63%,与改良Hodge试验相比,其敏感性为94.74%,特异性为93.22%。
多重耐药的该菌属正在增加。目前的研究表明,该菌的高耐药率可能是由于产ESBLs、AmpC和碳青霉烯酶所致。在所有β-内酰胺酶中,碳青霉烯酶产生菌在该菌属中更多且快速增加。能在所有临床实验室采用的快速、经济有效的检测方法对于预防其进一步传播至关重要,尤其是在医院环境中。